Huntsman DG - Search Results

1

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Anglesio MS, Kommoss S, Tolcher MC, Clarke B, Galletta L, Porter H, Damaraju S, Fereday S, Winterhoff BJ, Kalloger SE, Senz J, Yang W, Steed H, Allo G, Ferguson S, Shaw P, Teoman A, Garcia JJ, Schoolmeester JK, Bakkum-Gamez J, Tinker AV, Bowtell DD, Huntsman DG, Gilks CB, McAlpine JN. Anglesio MS, et al. Among authors: huntsman dg. J Pathol. 2013 Jan;229(1):111-20. doi: 10.1002/path.4088. J Pathol. 2013. PMID: 22899400

2

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.

3

Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Huntsman D, Resau JH, Klineberg E, Auersperg N. Huntsman D, et al. Am J Pathol. 1999 Aug;155(2):343-8. doi: 10.1016/S0002-9440(10)65130-9. Am J Pathol. 1999. PMID: 10433927 Free PMC article.

4

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB. Parker RL, et al. Among authors: huntsman dg. Am J Clin Pathol. 2002 May;117(5):723-8. doi: 10.1309/PEF8-GL6F-YWMC-AG56. Am J Clin Pathol. 2002. PMID: 12090420

5

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB. Hsu FD, et al. Mod Pathol. 2002 Dec;15(12):1374-80. doi: 10.1097/01.MP.0000039571.02827.CE. Mod Pathol. 2002. PMID: 12481020

6

Mechanisms of monozygotic (MZ) twinning: a possible role for the cell adhesion molecule, E-cadherin.

Bamforth F, Brown L, Senz J, Huntsman D. Bamforth F, et al. Am J Med Genet A. 2003 Jul 1;120A(1):59-62. doi: 10.1002/ajmg.a.20076. Am J Med Genet A. 2003. PMID: 12794693

7

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.

Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Makretsov N, et al. Hum Pathol. 2003 Oct;34(10):1001-8. doi: 10.1053/s0046-8177(03)00411-8. Hum Pathol. 2003. PMID: 14608533

8

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE. Nielsen TO, et al. Among authors: huntsman dg. Cancer Res. 2004 Jan 1;64(1):286-91. doi: 10.1158/0008-5472.can-03-1242. Cancer Res. 2004. PMID: 14729636

9

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis.

Dabiri S, Huntsman D, Makretsov N, Cheang M, Gilks B, Bajdik C, Gelmon K, Chia S, Hayes M. Dabiri S, et al. Mod Pathol. 2004 Jun;17(6):690-5. doi: 10.1038/modpathol.3800094. Mod Pathol. 2004. PMID: 15044916 Free article.

10

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Alkushi A, et al. Int J Gynecol Pathol. 2004 Apr;23(2):129-37. doi: 10.1097/00004347-200404000-00007. Int J Gynecol Pathol. 2004. PMID: 15084841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

499 results

Search Page